Botanical species · safety record

Dodonaea viscosa

The EFSA Compendium of Botanicals holds 15 constituent measurements for Dodonaea viscosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Dodonaea viscosa (L.) Jacq.

15Constituent measurements
0Safety records
9Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids2
  • Labdane diterpenes2
  • Saponins2
  • Tannins2
  • Clerodane-type diterpenes1
  • Coumarins1
  • Cyanogenic glycosides1
  • Eugenol1
  • Hautriwaic acid1
  • Oleanolic saponins1

Plant parts

  • Leaves8
  • Roots and other underground parts4
  • Aerial part of plants2
  • Stem1
  • stalk1

Preparations

  • Solvent extraction14
  • Thermal treatment (heating for preservation)1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Clerodane-type diterpenesLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
EugenolStem / stalkThermal treatment (heating for preservation)1.05 PercentGC-MSResolve DOI
Labdane diterpenesAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Labdane diterpenesLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Oleanolic saponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
P-coumaric acidAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
SaponinsLeavesSolvent extractionPhytochemical screeningResolve DOI
AlkaloidsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
CoumarinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Cyanogenic glycosidesLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Hautriwaic acidLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
SaponinsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Cao, Shugeng., Brodie, Peggy., Callmander, Martin., Randrianaivo, Richard., Razafitsalama, Jeremi., Rakotobe, Etienne., Rasamison, Vincent E., TenDyke, Karen., Shen, Yongchun., Suh, Edward M., Kingston, David G. I. Antiproliferative Triterpenoid Saponins of Dodonaea viscosa from the Madagascar Dry Forest. JOURNAL OF NATURAL PRODUCTS, 2009, vol. 72, no. 9, p. 1705-1707. DOI
  2. Khurram, Muhammad., Hameed, Abdul., Amin, Muhammad Usman., Gul, Ahtasham., Ullah, Naseem., Hassan, Mohammad., Qayum, Abdul., Chishti, Kamran Ahmad., Manzoor, Wajeeha. Phytochemical screening and in vitro evaluation of anticandidal activity of Dodonaea viscosa (L.) Jaeq. (Sapindaceae). AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, vol. 5, no. 11, p. 1422-1426.
  3. Shanmugavasan, A., Ramachandran, T. Investigation of the extraction process and phytochemical composition of preparations of Dodonaea viscosa (L.) Jacq.. JOURNAL OF ETHNOPHARMACOLOGY, 2011, vol. 137, no. 3, p. 1172-1176. DOI
  4. Salinas-Sanchez, David Osvaldo., Zamilpa, Alejandro., Perez, Salud., Herrera-Ruiz, Maribel., Tortoriello, Jaime., Gonzalez-Cortazar, Manases., Jimenez-Ferrer, Enrique. Effect of Hautriwaic Acid Isolated from Dodonaea viscosa in a Model of Kaolin/Carrageenan-Induced Monoarthritis. Planta Medica, 2015, p. 1240-1247.
  5. MATA, R., CONTRERAS, JL., CRISANTO, D., PEREDMIRANDA, R., CASTANEDA, P., DELRIO, F. CHEMICAL STUDIES ON MEXICAN PLANTS USED IN TRADITIONAL MEDICINE .18. NEW SECONDARY METABOLITES FROM DODONAEA-VISCOSA. JOURNAL OF NATURAL PRODUCTS, 1991, vol. 54, no. 3, p. 913-917. DOI
  6. Wabo, Hippolyte Kamdem., Chabert, Philippe., Tane, Pierre., Note, Olivier., Tala, Michel Feussi., Peluso, Jean., Muller, Christian., Kikuchi, Haruhisa., Oshima, Yoshiteru., Lobstein, Annelise. Labdane-type diterpenes and flavones from Dodonaea viscosa. FITOTERAPIA, 2012, vol. 83, no. 5, p. 859-863. DOI
  7. Rajamanickam, V., Rajasekaran, A., Anandarajagopal, K., Palanivelu, M., Jesupillai, M., Sivakumar, V. Anti-ulcer activity of various extracts of roots of Dodonaea viscosa. International journal of chemical sciences, 2009, p. 2675-2679.
  8. El-Gengaihi, Souad., Dimetry, Nadia Z., Amer, Sanaa A. A. Phytochemical, acaricidal and biological activity of Dodonaea viscosa L. against the two spotted spider mite Tetranychus urticae Koch. Archives of Phytopathology and Plant Protection, 2011, vol. 44, no. 5, p. 419-425. DOI
  9. Ortega, A., Garcia, PE., Cardenas, J., Mancera, C., Marquina, S., Garduno, MLD., Maldonado, E. Methyl dodonates, a new type of diterpenes with a modified clerodane skeleton from Dodonaea viscosa. TETRAHEDRON, 2001, vol. 57, no. 15, p. 2981-2989. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue